Filter by: patients
Home > Community Treatment Reports and Side Effects > Avelox Treatment Report
What is Avelox?

Avelox® is a brand name for the antibiotic drug moxifloxacin, used in the treatment of bacterial infections such as bronchitis and sinusitis. Off label it is used for Legionella.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 4 2 Efficacy_major Efficacy_slight
Pneumonia symptoms 3 1 Efficacy_moderate
Sinus Disease 2 1 Efficacy_moderate
Prevent infection 1 1 Efficacy_major
General health 1 0
bacterial/flu sx 1 0

See all 2 patients currently taking Avelox

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 2
Mild
 1
None
 3

Commonly reported side effects, conditions, and hospitalizations associated with Avelox

Nausea 2
Abdominal cramps 2

Reported Dosages

  400 mg daily
  2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Avelox (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 11   Course of treatment ended: 100%

See all 11 patients who’ve stopped taking Avelox

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Avelox

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Avelox

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Avelox

Always
 6 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Avelox

Very
 1 17%
Somewhat
 0 0%
A little
 1 17%
Not at all
 4 67%

Cost

Paid out of pocket

Cost of Avelox

$200+
 1 20%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 2 40%
< $25
 2 40%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.